Welcome back to plenary session, the podcast at the intersection of medicine, oncology, and health policy.

I'm your host, Vinay Prasad.

Today, I've got something special for you.

We did a six-panel Sensible Medicine Roundtable.

That's right.

There's a new podcast feed.

It's linked to the Sensible Medicine Substack magazine. It's S sensible medicine. It should be on the iTunes store. It should be on Google Podcasts. What do they like to say? Wherever podcasts are found, you'll find us. And yesterday we hosted, I think, our fifth episode was a roundtable discussion. We had Adam Cifu, we had John Mandrolo, we had Zubin Damania, we had Andrew Foy, we had Tracy Beth Hogg, we had myself.

We were talking about equipoise.

And this week, Rochelle Walensky made us talk about Equipoi.

She said there wasn't Equipoise to do a trial of masking.

You get six doctors together. We'll see if there's any equipoise. And what is equiopoise? And where does it come

from? And is it necessary and sufficient for the conduct of randomized controlled trials? Or

can there be a conception of randomized trials in the absence of equopoys? So I'm going to make

that audio available also on the plenary session podcast feed.

This is a crossover episode.

I'm doing it so you get a taste of what we're putting out on sensible medicine feed.

And sensible medicine is probably going to be panel discussions among the major writers of sensible medicine.

It's also open to submission.

I mean, if you have a submission, you want to write for a sensible medicine, go ahead and contact John or Adam or me or whomever you wish and see if it's a right fit.

There's also a sensible medicine Gmail account.

I think it's linked to the Twitter page.

So that's what we're going to be doing today's episode.

...